Log In

Item 9 Labs Corp (INLB)

Begins Capital Raise; Closes on First Dispensary Acquisition

‌
Joe GomesMedia Inquiries
Senior Generalist Equity Analyst
March 10, 2022
Report ID: 24566
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

‌
Item 9 Labs Corp
Ticker
INLB
Current Price
$0.00045 28.57%
Market Cap
$46.1K
Price Target
Refer to Report
Volume
20.2M
52wk Range
$0.0003 - $0.215
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
4/28/2023
‌
Termination of Research Coverage
Termination of Research Coverage (INLB)
0 min read
2/17/2023
‌
First Quarter Earnings Released
First Quarter Earnings Released (INLB)
4 min read
1/26/2023
‌
Reports 4Q and Full Year 2022 Results
Reports 4Q and Full Year 2022 Results (INLB)
6 min read
12/20/2022
‌
Going Into New Jersey
Going Into New Jersey (INLB)
0 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In